Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Charles River Laboratories International Inc shares valued at $550,000 were purchased by WALLMAN RICHARD F on Jun 23 ’25. At $137.50 per share, WALLMAN RICHARD F acquired 4,000 shares.
Also, MASSARO GEORGE sold 140 shares, netting a total of over 19,260 in proceeds. Following the sale of shares at $137.57 each, the insider now holds 5,575 shares.
Before that, MASSARO GEORGE had sold 140 shares from its account. In a trade valued at $19,703, the Director traded Charles River Laboratories International Inc shares for $140.73 each. Upon closing the transaction, the insider’s holdings decreased to 140 shares, worth approximately $0.86 million.
As published in a research note from Redburn Atlantic on May 23, 2025, Charles River Laboratories International Inc [CRL] has been rated up from a Neutral to a Buy and the price target has been revised to $182. Analysts at TD Cowen upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid May. As of May 08, 2025, Evercore ISI has increased its “an In-line” rating to a “an Outperform” for CRL. Earlier on March 21, 2025, Goldman downgraded its rating. Their new recommendation was “a Neutral” for CRL stock which previously was a “a Buy”.
Analyzing CRL Stock Performance
On last trading session,, Charles River Laboratories International Inc [NYSE: CRL] rose 1.22% to $150.21. The stock’s lowest price that day was $146.0, but it reached a high of $152.51 in the same session. During the last five days, there has been a surge of approximately 3.56%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -29.01%. Shares of the company reached a 52-week high of $193.56 on 01/07/25 and a 52-week low of $91.86 on 04/11/25.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
According to the 24-hour chart, there is a support level at 146.64, which, if violated, would cause prices to drop to 143.06. In the upper region, resistance lies at 153.15. The next price resistance is at 156.08. RSI (Relative Strength Index) is 60.97 on the 14-day chart, showing neutral technical sentiment.
Is Charles River Laboratories International Inc subject to short interest?
Stocks of Charles River Laboratories International Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.22 million shares to 2.42 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 2.64 million shares. A decline of -9.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.83 of the overall float, the days-to-cover ratio (short ratio) decline to 1.83.
Which companies own the most shares of Charles River Laboratories International Inc (CRL)?
In terms of Charles River Laboratories International Inc share price expectations, FactSet research, analysts set an average price target of 290 in the next 12 months, up nearly 95.42% from the previous closing price of $148.4. Analysts anticipate Charles River Laboratories International Inc stock to reach 465 by 2025, with the lowest price target being 151. In spite of this, 9 analysts ranked Charles River Laboratories International Inc stock as Buy at the end of 2025. On March 04, 2025, Citigroup assigned a price target of “a Neutral” to the stock and upgraded coverage with a $175.
